Lomitapide Medylate OverviewLomitapide (INN, marketed as Juxtapid in the US and as Lojuxta in the EU) is a drug used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals. It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate. The US Food and Drug Administration (FDA) approved lomitapide on 21 December 2012, as an orphan drug to reduc...
Read more Lomitapide Medylate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lomitapide
Recent Lomitapide Medylate Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 10mg, 20mg, 30mg, 40mg, 5mg, 60mg
- Capsule, Hard Gelatin: 5 mg, 10 mg, and 20 mg.
Other drugs which contain Lomitapide Medylate or a similar ingredient: (1 result)
- JUXTAPID Lomitapide Medylate